[In liver cirrhosis, not every "ammonia lowering drug" improves neuropsychiatric deficit].
D002986:Clinical Trials as Topic; D004151:Dipeptides / Q000627:therapeutic use*; D006501:Hepatic Encephalopathy / Q000188:drug therapy*; D022124:Hyperammonemia / Q000188:drug therapy*; D009483:Neuropsychological Tests; D016896:Treatment Outcome
D004151:Dipeptides; C002939:ornithylaspartate